CRL
Charles Riv Lab (CRL)
NYSE
$291.62+$4.79 (+1.67%)
Price as of Oct 02, 2026 4:27 PM EDT
  • $13.7B
    Market Cap
  • 63.57%
    1-Year Change
  • Diagnostics & Research
    Industry

Earnings Score

Score: 37
Valuation
CRL
vs History
vs S&P 500
Profitability
-0
Growth
-0
Low Earnings Volatility
0

Momentum Score

Score: 82
Valuation
CRL
vs History
vs S&P 500
3-Month Momentum
24.49%
12-Month Momentum
65.61%
3-Month Risk Adjusted Momentum
138.89%
12-Month Risk Adjusted Momentum
151.04%

True Yield

N/A
Valuation
CRL
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
3.12%
Net Debt Paydown Yield
0.54%

Financial Health Score

Score: 27
Valuation
CRL
vs History
vs S&P 500
Ohlson's O-Score
6